These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
539 related items for PubMed ID: 22898488
21. PNPLA3 I148M polymorphism and progressive liver disease. Dongiovanni P, Donati B, Fares R, Lombardi R, Mancina RM, Romeo S, Valenti L. World J Gastroenterol; 2013 Nov 07; 19(41):6969-78. PubMed ID: 24222941 [Abstract] [Full Text] [Related]
23. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease. Hotta K, Yoneda M, Hyogo H, Ochi H, Mizusawa S, Ueno T, Chayama K, Nakajima A, Nakao K, Sekine A. BMC Med Genet; 2010 Dec 22; 11():172. PubMed ID: 21176169 [Abstract] [Full Text] [Related]
27. Independent and joint correlation of PNPLA3 I148M and TM6SF2 E167K variants with the risk of coronary heart disease in patients with non-alcoholic fatty liver disease. Wu JT, Liu SS, Xie XJ, Liu Q, Xin YN, Xuan SY. Lipids Health Dis; 2020 Feb 24; 19(1):29. PubMed ID: 32093693 [Abstract] [Full Text] [Related]
28. Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant. Palmer CN, Maglio C, Pirazzi C, Burza MA, Adiels M, Burch L, Donnelly LA, Colhoun H, Doney AS, Dillon JF, Pearson ER, McCarthy M, Hattersley AT, Frayling T, Morris AD, Peltonen M, Svensson PA, Jacobson P, Borén J, Sjöström L, Carlsson LM, Romeo S. PLoS One; 2012 Feb 24; 7(6):e39362. PubMed ID: 22724004 [Abstract] [Full Text] [Related]
29. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Sookoian S, Pirola CJ. Hepatology; 2011 Jun 24; 53(6):1883-94. PubMed ID: 21381068 [Abstract] [Full Text] [Related]
36. Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease. Liu WY, Zheng KI, Pan XY, Ma HL, Zhu PW, Wu XX, Rios RS, Targher G, Byrne CD, Wang XD, Chen YP, Zheng MH. J Gastroenterol Hepatol; 2020 Jun 24; 35(6):1057-1064. PubMed ID: 31677195 [Abstract] [Full Text] [Related]
37. Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C. Trépo E, Pradat P, Potthoff A, Momozawa Y, Quertinmont E, Gustot T, Lemmers A, Berthillon P, Amininejad L, Chevallier M, Schlué J, Kreipe H, Devière J, Manns M, Trépo C, Sninsky J, Wedemeyer H, Franchimont D, Moreno C. Hepatology; 2011 Jul 24; 54(1):60-9. PubMed ID: 21488075 [Abstract] [Full Text] [Related]
38. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Rotman Y, Koh C, Zmuda JM, Kleiner DE, Liang TJ, NASH CRN. Hepatology; 2010 Sep 24; 52(3):894-903. PubMed ID: 20684021 [Abstract] [Full Text] [Related]
39. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C. Manchiero C, Nunes AKDS, Magri MC, Dantas BP, Mazza CC, Barone AA, Tengan FM. BMC Infect Dis; 2017 Dec 19; 17(1):780. PubMed ID: 29258449 [Abstract] [Full Text] [Related]